HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-(4-Fluorophenethyl)piperazin-2-one → tert-butyl 8-(4-(4-fluorophenethyl)-2-oxopiperazin-1-yl)-6-methyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-(4-Fluorophenethyl)piperazin-2-one | HCID 57514761 | — |
| Reactant | tert-Butyl 8-bromo-6-methyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate | HCID 66874851 | — |
| Product | tert-butyl 8-(4-(4-fluorophenethyl)-2-oxopiperazin-1-yl)-6-methyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate | HCID 66873645 | 76.1% |
Reaction Steps
tert-Butyl 8-bromo-6-methyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate (514 mg, 1.356 mmol) and 4-(4-fluorophenethyl)piperazin-2-one (301 mg, 1.356 mmol) were reacted following the procedure for Example 53 (step b) to provide the title compound (537 mg, 76%) as a white solid: ESI MS m/z 521 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08637501B2 |
| Source dataset | uspto-grants-2014_01 |
| ORD ID | ord-9f5d22023ad540368be6dc432c21dce0 |
| Source note | uspto-grants-2014_01 |